Charles Schwab’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $387K | Sell |
34,876
-6,829
| -16% | -$75.9K | ﹤0.01% | 3226 |
|
|
2025
Q1 | $584K | Sell |
41,705
-1,586
| -4% | -$22.2K | ﹤0.01% | 3025 |
|
|
2024
Q4 | $720K | Buy |
43,291
+5,855
| +16% | +$97.3K | ﹤0.01% | 3028 |
|
|
2024
Q3 | $708K | Buy |
37,436
+11,139
| +42% | +$211K | ﹤0.01% | 3032 |
|
|
2024
Q2 | $381K | Sell |
26,297
-11,069
| -30% | -$160K | ﹤0.01% | 3298 |
|
|
2024
Q1 | $578K | Buy |
37,366
+3,547
| +10% | +$54.9K | ﹤0.01% | 2968 |
|
|
2023
Q4 | $947K | Sell |
33,819
-4,009
| -11% | -$112K | ﹤0.01% | 2850 |
|
|
2023
Q3 | $1.8M | Buy |
37,828
+2,115
| +6% | +$101K | ﹤0.01% | 2630 |
|
|
2023
Q2 | $3.42M | Buy |
35,713
+4,020
| +13% | +$385K | ﹤0.01% | 2379 |
|
|
2023
Q1 | $3.59M | Sell |
31,693
-152
| -0.5% | -$17.2K | ﹤0.01% | 2345 |
|
|
2022
Q4 | $3.57M | Buy |
31,845
+692
| +2% | +$77.5K | ﹤0.01% | 2376 |
|
|
2022
Q3 | $4M | Buy |
31,153
+7,584
| +32% | +$974K | ﹤0.01% | 2331 |
|
|
2022
Q2 | $1.62M | Sell |
23,569
-540
| -2% | -$37K | ﹤0.01% | 2627 |
|
|
2022
Q1 | $3.43M | Buy |
24,109
+594
| +3% | +$84.6K | ﹤0.01% | 2457 |
|
|
2021
Q4 | $3.92M | Buy |
23,515
+221
| +0.9% | +$36.8K | ﹤0.01% | 2468 |
|
|
2021
Q3 | $3.24M | Buy |
23,294
+2,286
| +11% | +$318K | ﹤0.01% | 2577 |
|
|
2021
Q2 | $10M | Buy |
21,008
+1,889
| +10% | +$901K | ﹤0.01% | 2001 |
|
|
2021
Q1 | $7.87M | Buy |
19,119
+504
| +3% | +$208K | ﹤0.01% | 2078 |
|
|
2020
Q4 | $9.12M | Buy |
18,615
+1,480
| +9% | +$725K | ﹤0.01% | 1921 |
|
|
2020
Q3 | $9.7M | Sell |
17,135
-3,659
| -18% | -$2.07M | ﹤0.01% | 1717 |
|
|
2020
Q2 | $1.98M | Buy |
20,794
+1,321
| +7% | +$126K | ﹤0.01% | 2430 |
|
|
2020
Q1 | $1.39M | Buy |
19,473
+228
| +1% | +$16.3K | ﹤0.01% | 2406 |
|
|
2019
Q4 | $1.33M | Buy |
19,245
+174
| +0.9% | +$12K | ﹤0.01% | 2521 |
|
|
2019
Q3 | $1.53M | Buy |
19,071
+5,143
| +37% | +$413K | ﹤0.01% | 2466 |
|
|
2019
Q2 | $897K | Buy |
13,928
+7,153
| +106% | +$461K | ﹤0.01% | 2611 |
|
|
2019
Q1 | $931K | Buy |
6,775
+696
| +11% | +$95.6K | ﹤0.01% | 2572 |
|
|
2018
Q4 | $550K | Sell |
6,079
-46
| -0.8% | -$4.16K | ﹤0.01% | 2731 |
|
|
2018
Q3 | $930K | Buy |
6,125
+262
| +4% | +$39.8K | ﹤0.01% | 2650 |
|
|
2018
Q2 | $1.01M | Buy |
5,863
+928
| +19% | +$160K | ﹤0.01% | 2579 |
|
|
2018
Q1 | $725K | Buy |
4,935
+158
| +3% | +$23.2K | ﹤0.01% | 2621 |
|
|
2017
Q4 | $969K | Sell |
4,777
-387
| -7% | -$78.5K | ﹤0.01% | 2514 |
|
|
2017
Q3 | $1.66M | Buy |
5,164
+587
| +13% | +$188K | ﹤0.01% | 2349 |
|
|
2017
Q2 | $1.04M | Buy |
4,577
+25
| +0.5% | +$5.65K | ﹤0.01% | 2444 |
|
|
2017
Q1 | $1.03M | Buy |
4,552
+222
| +5% | +$50.1K | ﹤0.01% | 2413 |
|
|
2016
Q4 | $858K | Buy |
4,330
+1,200
| +38% | +$238K | ﹤0.01% | 2480 |
|
|
2016
Q3 | $770K | Buy |
3,130
+1,156
| +59% | +$284K | ﹤0.01% | 2469 |
|
|
2016
Q2 | $1.15M | Buy |
1,974
+799
| +68% | +$464K | ﹤0.01% | 2303 |
|
|
2016
Q1 | $624K | Buy |
1,175
+23
| +2% | +$12.2K | ﹤0.01% | 2490 |
|
|
2015
Q4 | $809K | Buy |
1,152
+371
| +48% | +$261K | ﹤0.01% | 2459 |
|
|
2015
Q3 | $463K | Buy |
+781
| New | +$463K | ﹤0.01% | 2651 |
|